Affordable Access

deepdyve-link
Publisher Website

Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirin.

Authors
  • Larrey, Dominique
  • Carenco, Christophe
  • Guyader, Dominique
  • Boyer, Nathalie
  • Benhamou, Yves
  • Pageaux, Georges-Philippe
  • Rouzier, Regine
  • Marcellin, Patrick
Type
Published Article
Journal
Diabetes care
Publication Date
Jan 01, 2012
Volume
17
Issue
5
Pages
927–932
Identifiers
DOI: 10.3851/IMP2126
PMID: 22611092
Source
USPC - SET - SVS
License
Unknown

Abstract

The addition of danoprevir for 14 days to PEG-IFN/RBV treatment results in a high SVR rate in HCV genotype 1 treatment-naive patients.

Report this publication

Statistics

Seen <100 times